Rocket Lab Gains FTSE Index Inclusion Amid Mixed Market Signals

Rocket Lab USA has achieved a milestone with its inclusion in the FTSE All-World Index, a move that significantly elevates its profile among institutional investors. This development arrives as the aerospace company demonstrates robust operational growth, yet faces headwinds from a substantial new share offering and a key program delay.

Analyst Sentiment and Financial Performance

Market analysts maintain a favorable outlook on the company, with a consensus rating of “Moderate Buy.” The average price target stands at $90.73, representing a potential upside of approximately 35% from current trading levels. This optimism is underpinned by strong financial results; for the 2025 fiscal year, Rocket Lab reported revenue of $602 million, marking a 38% year-over-year increase.

Record Contract and Expanding Backlog

A significant driver of growth is a landmark $190 million contract awarded by the U.S. Department of Defense. This agreement, the largest launch contract in the company’s history, involves conducting 20 hypersonic test flights over four years under the Pentagon’s MACH-TB 2.0 program. Kratos Defense will serve as the primary contractor for specific project elements.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

This major award has pushed Rocket Lab’s total contract backlog beyond the $2 billion threshold. This backlog encompasses an estimated 70 planned launches alongside various projects within its Space Systems division.

Capital Raise and Program Delay Weigh on Shares

On March 18, the company announced a planned equity offering aimed at raising $1 billion to fund ongoing operations and infrastructure development. This news has pressured the stock, compounding investor concerns about share dilution following a previous capital raise of $749 million. Year-to-date, the share price has declined by about 12%.

Further impacting investor sentiment is a schedule adjustment for the Neutron rocket program. The inaugural launch has been postponed to the fourth quarter of 2026 following a test incident where a tank ruptured. Despite this setback, analyst confidence appears largely unchanged, as reflected in the sustained “Moderate Buy” recommendation.